Full Length Research Paper
References
|
Alfouzan W, Dhar R, Ashkanani H, Gupta M, Rachel C, Khan ZU (2015). Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait. Journal of Medical Mycology 25:23-28. |
|
|
Badiee P, Alborzi A (2011). Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five years study. Iranian Journal of Microbiology 3(4):183-188. |
|
|
Belayneh M, Sehn E, Korownyk C (2017). Recurrent vulvovaginal candidiasis. Canadian Family Physician 63(6):455. |
|
|
Cuenca-Estrella M, Gomez-Lopez A, Alastruey-Izquierdo A, Bernal-Martinez L, Cuesta I, Buitrago MJ, Rodriguez-Tudela J L (2010). Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques for In Vitro Detection of Antifungal Resistance in Yeast Isolates. Journal of Clinical Microbiology 48(5):1782-1786. |
|
|
Dieng Y (2001). Antifungal susceptibility of Candida strains responsible of oropharyngeal candidiasis chez des patients living with HIV. Dakar Medical 2:835. |
|
|
Dignani MC, Solomkin JS, Anaissie EJ (2009). Candida. Clinical Mycology 2nd ed. Edinburgh: Churchill Livingstone, pp. 197-229. |
|
|
Diongue K, Baha Z, Seck MC, Ndiaye M, Diallo MA, Ndiaye D (2018a). [Cases of skin and nail candidiasis diagnosed at the parasitology and mycology laboratory of Le Dantec University Hospital in Dakar, 2008-2015]. Médecine et Santé Tropicales 28(4):390-394. |
|
|
Diongue K, Kébé O, Faye MD, Samb D, Diallo MA, Ndiaye M (2018b). MALDI-TOF MS identification of Malassezia species isolated from patients with pityriasis versicolor at the seafarers' medical service in Dakar, Senegal. Journal of Medical Mycology 28:590-593. |
|
|
Djohan V, Angora KE, Vanga-Bosson AH, Konaté A, Kassi FK, Yavo W, Kiki-Barro PC, Menan H, Kone M (2012). [In vitro susceptibility of vaginal Candida albicans to antifungal drugs in Abidjan (Ivory Coast)]. Journal of Medical Mycology 22(2):129-133. |
|
|
ElFeky DS, Gohar NM, El-Seidi EA, Ezzat MM, AboElew SH (2016). Species identification and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal candidiasis. Alexandria Journal of Medicine 52:269-277. |
|
|
EUCAST. Antifungal Clinical Breakpoint Table v. 9.0 (2019). |
|
|
Fornari G, Vicente VA, Gomes RR, Muro MD, Pinheiro RL, Ferrari C (2016). Susceptibility and molecular characterization of Candida species from patients with vulvovaginitis. Brazilian Journal of Microbiology 47:373-380. |
|
|
Gonzalez-Lara MF, Torres-Gonzalez P, Rangel-Cordero A, Sifuentes-Osornio J, Ponce-de-Leon A, Martinez-Gamboa A (2017). Identification and susceptibility testing of Candida spp. directly from yeast-positive blood cultures with Vitek 2. Diagnostic Microbiology and Infectious Disease 89(3):202-204. |
|
|
Kechrid A (2018). MALDI-TOF MS contribution in identification of Candida species responsible of vulvovaginal candidiasis. Final dissertation of Specialized Study in Clinical Biology, Dakar 306:31-35. |
|
|
Lirio J, Giraldo PC, Amaral RL, Alves Sarmento AC, Ferreira Costa AP, Gonçalves AK (2019). Antifungal (Oral and Vaginal) Therapy for Recurrent Vulvovaginal Candidiasis: A Systematic Review Protocol. BMJ Open 9:e027489. |
|
|
Liu XP, Fan SR, Peng YT, Zhang HP (2014). Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. Journal of Medical Mycology 24(2):106-111. |
|
|
Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG (2007). Multicenter Comparison of the VITEK 2 Antifungal Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Amphotericin B, Flucytosine, and Voriconazole against Candida spp. Journal of Clinical Microbiology 45(11):3522-3528. |
|
|
Posteraro B, Martucci R, La Sorda M, Fiori B, Sanglard D, De Carolis E, Florio AR, Fadda G, Sanguinetti M (2009). Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata. Journal of Clinical Microbiology 47(6):1927-1930. |
|
|
Pristov KE, Ghannoum MA (2019). Resistance of Candida to azoles and echinocandins worldwide. Clinical Microbiology and Infection 25:792e798. |
|
|
Revie NM, Iyer KR, Robbins N, Cowen LE (2018). Antifungal drug resistance: evolution, mechanisms and impact. Current Opinion in Microbiology 45:70-76. |
|
|
Scapaticci M, Bartolini A, Del Chierico F, Accardi C, Di Girolamo F, Masotti A, Muraca M, Putignani L (2018). Phenotypic typing and epidemiological survey of antifungal resistance of Candida species detected in clinical samples of Italian patients in a 17 months' period. Germs 8(2):58-66. |
|
|
Sobel JD (2016). Recurrent Vulvovaginal Candidiasis: Review. American Journal of Obstetrics and Gynecology 214(1):15-21. |
|
|
Sy O, Diongue K, Ahmed CB, Ba O, Moulay FC, Lo B, Ndiaye D (2018). [Vulvovaginal candidiasis in pregnant women in the Mère et Enfant Hospital center in Nouakchott, Mauritania]. Journal of Medical Mycology 28:345-348. |
|
|
Sylla K, Tine RC, Ndiaye LA, Sow D, Lélo S, Dia M, Dieng T (2019). Distribution of Candida Species and Their Susceptibility to Antifungal Drugs in Dakar, Senegal. International Journal of Infectious Diseases and Therapy 4(4):50-55. |
|
|
Yaman G, Akyar I, Can S (2012). Evaluation of the MALDI-TOF MS method for identification of Candida strains isolated from blood cultures. Diagnostic Microbiology and Infectious Disease 73(1):65-67. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
